RecruitingNCT05266664
Preterm Immune System Development and Response to Immunization
Sponsor
Maastricht University Medical Center
Enrollment
145 participants
Start Date
Dec 8, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
In this study the response to vaccination and development of the immune system in very preterm infants upon the current vaccination schedule will be compared to healthy term infants.
Eligibility
Min Age: 1 DayMax Age: 2 Months
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with immune system disorder, preterm, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 1 Day to 2 Months.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05266664
Related Trials
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm
NCT062407159 locations
Sensory Optimization of the Hospital Environment
NCT052301991 location
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
NCT039087361 location
SAFE Early Intervention for At-Risk Infants
NCT075961471 location
Assessing Intellectual and Motor Outcomes in High-risk Infants
NCT068575394 locations